切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2026, Vol. 20 ›› Issue (06) : 454 -464. doi: 10.3877/cma.j.issn.1674-0785.2026.06.006

基础研究

FTO在AngⅡ诱导内皮细胞损伤中的作用及其与NF-κB通路的相关性分析
苟于芬1, 王宏宇2,†()   
  1. 1 830054 新疆乌鲁木齐,新疆医科大学第二临床医学院
    2 100144 北京,北京大学首钢医院血管医学中心
  • 收稿日期:2026-05-07 出版日期:2026-06-30
  • 通信作者: 王宏宇

Association of FTO expression changes with Ang Ⅱ-induced endothelial injury and NF-κB pathway activation in HUVECs

Yufen Gou1, Hongyu Wang2,†()   

  1. 1 The Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
    2 Peking University Shougang Hospital Vascular Medicine Center, Beijing 100144, China
  • Received:2026-05-07 Published:2026-06-30
  • Corresponding author: Hongyu Wang
引用本文:

苟于芬, 王宏宇. FTO在AngⅡ诱导内皮细胞损伤中的作用及其与NF-κB通路的相关性分析[J/OL]. 中华临床医师杂志(电子版), 2026, 20(06): 454-464.

Yufen Gou, Hongyu Wang. Association of FTO expression changes with Ang Ⅱ-induced endothelial injury and NF-κB pathway activation in HUVECs[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2026, 20(06): 454-464.

目的

探讨FTO表达变化与AngⅡ诱导的人脐静脉内皮细胞(HUVECs)损伤及NF-κB信号通路之间的相关性。

方法

构建AngⅡ诱导的HUVECs损伤模型,通过FTO过表达及抑制干预,采用CCK-8、划痕、Transwell、流式细胞术及ELISA检测细胞功能及炎症变化,并检测NF-κB相关蛋白磷酸化水平。

结果

AngⅡ刺激可显著降低HUVECs细胞活力及迁移能力,并诱导TNF-α及IL-6表达升高,同时伴随NF-κB相关蛋白磷酸化水平变化。FTO表达改变与AngⅡ诱导的细胞功能损伤、炎症因子水平变化及NF-κB通路磷酸化改变同步伴随,存在统计学关联。相关分析显示,NF-κB磷酸化水平与炎症因子表达之间未呈现一致的变化趋势,即FTO过表达组NF-κB磷酸化水平高于对照组,但炎症因子水平低于AngⅡ组;FTO抑制组则呈现相反趋势。

结论

FTO表达变化与AngⅡ诱导的内皮细胞功能改变及NF-κB信号磷酸化水平变化之间存在统计学关联。本研究为体外观察性实验,尚不能确定上述变量之间的因果关系,相关机制有待进一步验证。

Objective

Endothelial dysfunction induced by Angiotensin Ⅱ (Ang Ⅱ) plays a critical role in the development of hypertension-related vascular injury. However, the potential role of fat mass and obesity-associated protein (FTO) in this process, as well as its interplay with the NF-κB signaling pathway, remains unclear. This study aimed to investigate whether FTO modulates Ang Ⅱ-induced endothelial dysfunction and to explore its mechanistic association with NF-κB pathway activation in human umbilical vein endothelial cells (HUVECs).

Methods

An Ang Ⅱ-induced injury model was established in HUVECs. Following FTO overexpression and knockdown, cell viability, migration, cell cycle distribution, and inflammatory factor levels were evaluated using CCK-8, wound healing and Transwell, flow cytometry, and ELISA assays. Phosphorylation levels of NF-κB-related proteins were measured by Western blotting.

Results

Ang Ⅱ stimulation significantly reduced cell viability and migration of HUVECs, accompanied by increased levels of TNF-α and IL-6, as well as altered phosphorylation of NF-κB-related proteins. Alterations in FTO expression paralleled changes in Ang II-induced endothelial dysfunction and inflammatory responses, and were associated with shifts in NF-κB signaling phosphorylation. Notably, correlation analysis revealed no consistent trend between NF-κB phosphorylation levels and inflammatory cytokine expression: FTO overexpression was associated with elevated NF-κB phosphorylation but reduced inflammatory cytokines compared to the Ang Ⅱ group, whereas FTO inhibition produced the opposite trend.

Conclusion

FTO expression changes correlate with Ang Ⅱ-induced endothelial dysfunction and NF-κB signaling phosphorylation changes in HUVECs. As an observational in vitro study, these findings do not establish causality, and the underlying mechanisms warrant further investigation.

图1 FTO过表达效率验证。图a为FTO Western blot条带图;图b为FTO蛋白定量柱状图;图c为qPCR定量柱状图 注:数据以mean±SD表示,n=3独立生物学重复;组间比较采用单因素方差分析联合Dunnett多重比较检验;与空白对照组相比,*P<0.05;***P<0.001;ns表示差异无统计学意义;Control为空白对照组,OE-NC为空载慢病毒对照组;OE-FTO为FTO过表达组
图2 FTO过表达对HUVECs细胞活力的影响 注:CCK-8细胞活力折线图,横轴为培养时间,纵轴为细胞相对活力;数据以mean±SD表示,n=3独立生物学重复;组间比较采用单因素方差分析联合Dunnett多重比较检验。与OE-NC空载对照组相比,***P<0.001;Control为空白对照组;OE-NC为空载慢病毒对照组;OE-FTO为FTO过表达组
图3 FTO过表达对HUVECs迁移能力的影响。图a为划痕实验代表性图像与划痕愈合率定量柱状图;图b为Transwell染色图像与迁移细胞计数柱状图 注:数据以mean±SD表示,n=3独立生物学重复;组间比较采用单因素方差分析联合Dunnett多重比较检验;与OE-NC空载对照组相比,**P<0.01,***P<0.001;ns为差异无统计学意义;Control为空白对照组;OE-NC为空载慢病毒对照组;OE-FTO为FTO过表达组
图4 FTO对HUVECs细胞周期分布的影响。图a为流式细胞周期散点图;图b为各周期细胞比例定量柱状图 注:数据以mean±SD表示,n=3独立生物学重复;组间比较采用单因素方差分析联合Dunnett多重比较检验;*P<0.05,**P<0.01;ns为差异无统计学意义;Control为空白对照组;OE-NC为空载慢病毒对照组;OE-FTO为FTO过表达组
图5 FTO及NF-κB与AngⅡ诱导内皮损伤中的关联 注:CCK-8细胞活力折线图,横轴为培养时间,纵轴为细胞相对活力。数据以mean±SD表示,n=3独立生物学重复;组间整体比较采用单因素方差分析,两两比较采用单因素方差分析+Tukey多重检验;与Control组相比,***P<0.001;与OE-FTO+AngⅡ组相比,***P<0.001;与AngⅡ组相比,***P<0.001;与FB23+JSH23+AngⅡ组相比,*P<0.05;AngⅡ为血管紧张素Ⅱ;FB23为FTO选择性抑制剂;JSH2为NF-κB通路抑制剂;NF-κB为核因子κB
图6 FTO及NF-κB与内皮细胞迁移能力的关联。图a为划痕实验图像与愈合率统计;图b为Transwell染色图像与迁移细胞计数 注:数据以mean±SD表示,n=3独立生物学重复;两两比较采用单因素方差分析+Tukey多重检验;与Control组相比,***P<0.001;与OE-FTO+AngⅡ组相比,***P<0.001、**P<0.01;与AngⅡ组相比,***P<0.001;与FB23+JSH23+AngⅡ组相比,***P<0.001、**P<0.01;AngⅡ为血管紧张素Ⅱ;FB23为FTO选择性抑制剂;JSH23为NF-κB通路抑制剂;NF-κB为核因子κB
图7 FTO及NF-κB与细胞周期分布的关联。图a为流式周期散点图;图b为周期比例定量柱状图 注:图数据以mean±SD表示,n=3独立生物学重复;两两比较采用单因素方差分析+Tukey多重检验;与Control组相比,*P<0.05;与OE-FTO+AngⅡ组相比,***P<0.001、*P<0.05;与AngⅡ组相比,*P<0.05、**P<0.01;与FB23+JSH23+AngⅡ组相比,*P<0.05;AngⅡ为血管紧张素Ⅱ;FB23为FTO选择性抑制剂;JSH23为NF-κB通路抑制剂;NF-κB为核因子κB
图8 FTO及NF-κB与炎症因子水平的关联。图a为各组TNF-α上清浓度定量柱状图;图b为各组IL-6浓度柱状图 注:数据以mean±SD示,n=3独立生物学重复;两两比较采用Tukey多重检验;与Control组相比,***P<0.001;与OE-FTO+AngⅡ组相比,***P<0.001;与AngⅡ组相比,***P<0.001;与FB23+JSH23+AngⅡ组相比,***P<0.001;AngⅡ为血管紧张素Ⅱ;FB23为FTO选择性抑制剂;JSH23为NF-κB通路抑制剂;NF-κB为核因子κB
图9 NF-κB信号通路相关蛋白表达变化。图a、b分别为总p65、磷酸化p-p65的Western blot图与灰度定量柱状图;图c、d分别为总IκBα、磷酸化p-IκBα的Western blot图与定量统计 注:蛋白相对表达量以目的蛋白灰度值与内参GAPDH/β-Actin灰度比值计算;数据以mean±SD表示,n=3独立生物学重复;两两比较采用Tukey多重检验。与Control组相比,**P<0.01;与OE-FTO+AngⅡ组相比,*P<0.05;与AngⅡ组相比,*P<0.05;与FB23+JSH23+AngⅡ组相比,*P<0.05;ns为差异无统计学意义;AngⅡ为血管紧张素Ⅱ;FB23为FTO选择性抑制剂,JSH23为NF-κB通路抑制剂;NF-κB为核因子κB
1
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension [J]. Nat Rev Nephrol, 2020, 16(4): 223-237.
2
Ferrario CM. Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension:An overview [J]. Drugs, 1990, 2: 1-8.
3
Granger JP, Schnackenberg CG. Renal mechanisms of angiotensin Ⅱ-induced hypertension [J]. Semin Nephrol, 2000, 20(5): 417-425.
4
Miura SI, Matsuo Y, Seumatsu Y. Renin-angiotensin-aldosterone system and its relation to hypertension [J]. Hypertens Res, 2025, 48(8): 2209-2217.
5
Qi J, Yu XJ, Shi XL, et al. NF-κB Blockade in hypothalamic paraventricular nucleus inhibits high-Salt-Induced Hypertension Through NLRP3 and Caspase-1 [J]. Cardiovasc Toxicol, 2016, 16(4): 345-354.
6
李娜, 张岩, 贾营. NF-κB/RBP4信号通路与高血压患者炎症因子变化的相关性 [J]. 临床和实验医学杂志, 2021, 20(24): 2592-2595.
7
Xu ZY, Jing X, Xiong XD. Emerging role and mechanism of the FTO gene in cardiovascular diseases [J]. Biomolecules, 2023, 13(5): 850.
8
Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity [J]. Science, 2007, 316(5826): 889-894.
9
Krüger N, Biwer LA, Good ME, et al. Loss of endothelial FTO antagonizes obesity-induced metabolic and vascular dysfunction [J]. Circ Res, 2020, 126(2): 232-242.
10
刘滴, 李云瞾, 周刚, 等. 去甲基化酶FTO在心血管疾病中的研究进展 [J]. 生命的化学, 2021, 41(3): 552-557.
11
Zhou C, She X, Gu C, et al. FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1 [J]. J Clin Invest, 2023, 133(19): e160517.
12
Shan L, Tao M, Zhang W, et al. Comprehensive analysis of the m6A demethylase FTO in endothelial dysfunction by MeRIP sequencing [J]. Exp Cell Res, 2024, 442(2): 114268.
13
Mo W, Chen Z, Zhang X, et al. N6-Methyladenosine demethylase FTO (fat mass and obesity-associated protein) as a novel mediator of statin effects in human endothelial cells [J]. Arterioscler Thromb Vasc Biol, 2022, 42(5): 644-658.
14
Dubey PK, Patil M, Singh S, et al. Increased m6A-RNA methylation and FTO suppression is associated with myocardial inflammation and dysfunction during endotoxemia in mice [J]. Mol Cell Biochem, 2022, 477(1): 129-141.
15
Zhang F, Zhang L, Wang Y. m6A RNA methylation in sepsis-induced cardiomyopathy: direct cardiac mechanisms, emerging therapeutic targets, and translational gaps [J]. Front Med (Lausanne), 2026, 13: 1826751.
16
薛凤麟. NF-κB在AngⅡ调控HUVEC细胞生存/凋亡信号通路中的作用研究[D]. 昆明: 昆明医科大学, 2007.
17
Chen LS, Zhang M, Chen P, et al. The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG [J]. Acta Pharmacol Sin, 2022, 43(5): 1311-1323.
18
Fu C, Jiang W, Wang C, et al. AP001885.4 promotes the proliferation of esophageal squamous cell carcinoma cells by histone lactylation- and NF-κB (p65)-dependent transcription activation and METTL3-mediated mRNA stability of c-myc [J]. Anim Cells Syst (Seoul), 2024, 28(1): 536-550.
19
Gao L, Wang A, Chen Y, et al. FTO facilitates cancer metastasis by modifying the m6A level of FAP to induce integrin/FAK signaling in non-small cell lung cancer [J]. Cell Commun Signal, 2023, 21(1): 311.
20
Yang Z, Xiong M, Tang X, et al. Ginsenoside Rb1 mitigates atherosclerosis in part through modulating FTO-mediated m6A RNA modification in NETs-induced endothelial activation [J]. Front Pharmacol, 2025, 16: 1631076.
21
Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO [J]. Nat Chem Biol, 2011, 7(12): 885-887.
22
Zhao M, Joy J, Zhou W, et al. Transcriptional outcomes and kinetic patterning of gene expression in response to NF-κB activation [J]. PLoS Biol, 2018, 16(9): e2006347.
23
Ajoolabady A, Pratico D, Ren J. Angiotensin Ⅱ: Role in oxidative stress, endothelial dysfunction, and diseases [J]. Mol Cell Endocrinol, 2024, 592: 112309.
24
Pueyo ME, Gonzalez W, Nicoletti A, et al. Angiotensin Ⅱ stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress [J]. Arterioscler Thromb Vasc Biol, 2000, 20(3): 645-651.
25
Hayden MS, Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions [J]. Genes Dev, 2012, 26(3): 203-234.
26
Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation [J]. Cold Spring Harb Perspect Biol, 2009, 1(4): a000034.
27
Yu H, Lin L, Zhang Z, et al. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study [J]. Signal Transduct Target Ther, 2020, 5(1): 209.
28
Wang Y, Xiang GS, Kourouma F, et al. Citrobacter rodentium-induced NF-kappaB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylation [J]. Br J Pharmacol, 2006, 148(6): 814-824.
29
Kumar A, Negi G, Sharma SS. JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence [J]. Diabetes Obes Metab, 2011, 13(8): 750-758.
30
Chen L, Deng H, Cui H, et al. Inflammatory responses and inflammation-associated diseases in organs [J]. Oncotarget, 2017, 9(6): 7204-7218.
31
Roundtree IA, Evans ME, Pan T, et al. Dynamic RNA modifications in gene expression regulation [J]. Cell, 2017, 169(7): 1187-1200.
32
He PC, He C. m6A RNA methylation: from mechanisms to therapeutic potential [J]. EMBO J, 2021, 40(3): e105977.
[1] 朱琳, 谭玉靓, 贺飞, 王佳妮. 激素受体阳性/HER-2阴性乳腺癌术后阿贝西利相关性间质性肺炎一例[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(04): 261-263.
[2] 李莹, 潘静. 慢性乙型肝炎肝硬化程度与C-反应蛋白-白蛋白-淋巴细胞指数的相关性及其不良预后的影响因素[J/OL]. 中华实验和临床感染病杂志(电子版), 2026, 20(04): 239-245.
[3] 曹伊凡, 胡良晨, 徐冉冉, 赵春霞, 张梓钰, 李若林, 徐鹏, 李相元. 以假瘤样脱髓鞘病变为表现的髓鞘少突胶质细胞糖蛋白抗体相关性疾病一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2026, 20(02): 122-128.
[4] 袁浩宇, 肖远松, 杨成林, 胡正飞, 王志勇, 杨悦. 全腹腔镜下回肠膀胱扩大术治疗氯胺酮相关性膀胱炎的疗效[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(02): 154-158.
[5] 王凤玉, 肖烨, 苏可婕, 魏鑫, 陈高红. 体重指数与Ⅰ型食管裂孔疝多层螺旋CT测量的相关性分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2026, 20(05): 552-556.
[6] 黄丛秀, 王少军, 郁志龙, 苏乌云, 刘彩霞, 孙晓革. 局部晚期非小细胞肺癌放疗联合免疫治疗并发治疗相关性肺炎的危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(04): 566-571.
[7] 张国欣, 郭秉权, 安云刚, 陈俊卿, 李悦, 张建锋. 免疫检查点抑制剂治疗后自发性坏死肠黏膜排出一例[J/OL]. 中华结直肠疾病电子杂志, 2026, 15(04): 372-374.
[8] 刘富丽, 李丹, 陈燕, 段慧, 李姣, 周正奎. 功能性便秘患者胃肠电图参数与临床特征的相关性及其对不同亚型的诊断价值分析[J/OL]. 中华结直肠疾病电子杂志, 2026, 15(03): 244-255.
[9] 李润方, 武志峰. 自适应光学光学相干断层扫描在黄斑疾病中应用的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2026, 16(02): 101-105.
[10] 杨悦, 张正威. 光学相干断层扫描成像中脉络膜高反射灶的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2026, 16(01): 54-58.
[11] 海花, 陈金金, 徐国彬, 孟辉, 王淼, 王威. 血清胃泌素与胃蛋白酶原Ⅰ、Ⅱ联合24 h食管pH-阻抗监测诊断胃食管反流相关性胸痛的价值[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(05): 438-444.
[12] 孙娟华, 白引苗, 孔胜男, 王梦雪, 王文慧, 张红梅. 胰腺癌患者化疗相关性恶心呕吐风险列线图构建及验证[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(02): 114-119.
[13] 魏子杰, 陈欣欣, 姚瑶, 闫振宇. 老年代偿期肝硬化患者膳食炎症指数、营养参数与衰弱发生风险的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(02): 167-172.
[14] 向健, 刘莉. 血清IL-1、PAF与急性大出血合并输血相关性急性肺损伤患者预后不良的关系[J/OL]. 中华临床实验室管理电子杂志, 2026, 14(02): 134-140.
[15] 邓双逍, 韦静静, 周保纯. 脓毒症的脑功能监测——重点关注脑电图[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(03): 342-346.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?